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Cerebral palsy is a major neonatal handicap with unknown aetiology. There is evidence that prenatal brain injury is the leading
cause of CP. Severe placental pathology accounts for a high percentage of cases. Several factors predispose to prenatal brain damage
but when and how they act is unclear. The aim of this paper was to determine if hypoxia during pregnancy leads to damage in
fetal brain and to evaluate the localization of this injury. An animal model of chronic hypoxia produced by chronic administration
of a nitric oxide synthase inhibitor (L-NAME) was used to evaluate apoptotic activity in fetal brains and to localize the most
sensitive areas. L-NAME reproduces a preeclamptic-like condition with increased blood pressure, proteinuria, growth restriction
and intrauterine mortality. Apoptotic activity was increased in L-NAME brains and the most sensitive areas were the subventricular
and pallidum zone. These results may explain the clinical features of CP. Further studies are needed.
1. Introduction
Two of every 1000 children born alive will develop some
degree of cerebral palsy (CP). Even though its aetiology is
unknown, there is increasing evidence that prenatal brain
injury is the leading cause of CP rather than peripar-
tum brain insult [1], especially prenatal hypoxic-ischemic
encephalopathys [2]. Prematurity, hypoxia, ischemia, and
inflammation are clinical factors that predispose to prenatal
brain damage, but when and how they act is unclear.
Preeclampsia (PE) aﬀects 8–10% of pregnancies world-
wide [3]. It has been shown in several studies that chil-
dren born from preeclamptic mothers may have a various
degree of neurodevelopmental delay. Long-term eﬀects have
been reported in newborns with growth restriction added
to a preeclamptic [4, 5]. Severe placental pathology, as
preeclampsia, accounts for 21 percent of all cases of cerebral
palsy in an Australian cohort [6]. The mechanism of brain
damage caused by maternal hypoxia in oﬀspring is not clear.
It has been reported that acute prenatal hypoxia altered the
structural and functional properties of cell membranes and
initiated apoptotic gene transcription [7], but most previous
studies have employed models of acute cerebral hypoxia-
ischemia in postnatal animals [8].
The location of the neurological damage should explain
the clinical features in cerebral palsy, but neonatal imaging
findings in hypoxic-ischemic injury are highly variable and
depend on a number of factors, including brain maturity,
severity and duration of insult, and type and timing of
imaging studies [9]. De Vries et al. described the existence of
periventricular hemorrhages in fetuses with chronic hypoxia
and PE [10, 11]. However, no clear correspondence has been
described between the location of the haemorrhage and the
long term outcome and handicaps the neonate will develop.
None of the areas most sensitive to hypoxic insult have
yet been clarified. Severe asphyxia in animals at term showed
that progenitors within the subventricular zone (SVZ) are
vulnerable to this insult [12], and also a neuronal loss in
the hippocampus after prenatal hypoxia has been described
[13, 14].
The main aim of our study was to determine if hypoxic
situation during pregnancy leads to a damage in the fetal
brain, and to evaluate the localization of this prenatal injury.
We used an animal model for this purpose, in which we
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reproduced a PE-like condition by chronic inhibition of
nitric oxide synthase (NOS) during gestation in rats. It results
in pathological changes similar to those observed in women
with preeclampsia, such as severe renal vasoconstriction,
proteinuria, thrombocytopenia, and intrauterine growth
restriction [15, 16].
2. Material and Methods
2.1. Animals and Study Design. Female Wistar rats approx-
imately 10 weeks of age and weighing 200–250 g, were
maintained at constant room temperature (22◦C), 60%
relative humidity, for a 12 hour dark-light cycles with
standard feeding. Animals were randomly allocated in two
experimental groups.
A first group were animals had food and tap water ad
libitum was the control group (n = 15), and a second
group were animals receives 50 mg/Kg/day of L-NAME, a
nitric oxide synthase inhibitor, dissolved in drinking water
since day 0 of pregnancy (E0) were named L-NAME group
(n = 15).
To study the eﬀect of NOS inhibition on the foetuses, we
established sacrifice days which corresponded with the first,
second, and third trimesters in human pregnancies [17, 18].
Five mothers by group were sacrificed on gestational days E8,
E11, and E18 and the foetal cerebral tissues were fixed for
further analysis.
The study was performed in accordance with European
Directive 86/609/CEE and the guidelines of the National
Institutes of Health (NIH) for the care and use of laboratory
animals. The study protocol used was approved by the ethics
committee of the Centro de Investigacio´n Prı´ncipe Felipe
(CIPF), Valencia, Spain.
2.2. Systolic Blood Pressure (SBP). We obtained SBP values
using a noninvasive automatic blood pressure analyzer
(NIPREM 564, Cibertec, Madrid, Spain) attached to the rat’s
tail after previously dilating the vessels with a stove (36-37◦C)
for 5 minutes, as described elsewhere [19, 20]. The mean of 5
readings from each animal was considered as the individual
SBP value. The measurements were performed on gestational
days E1, E8, E11 and E18 in both groups.
2.3. Perinatal Outcome. Various approaches were followed to
analyse the weight of the diﬀerent structures. On gestational
days E8 and E11, we measured the weight of a section of
the pregnant uterus between the implantation sites, which
included both the foetuses and the associated uterine walls
[20]. On gestational day E18 the crown-rump (CRL) and
occipital-snout lengths (OSL) were measured. The placental
weight was recorded, and foetal organs were macroscopically
reviewed in 5 foetuses per group to rule out congenital
anomalies. Cerebral and hepatic organs were extracted and
weighted.
Antenatal and perinatal mortality were also studied.
Intrauterine mortality was calculated on gestational day E8,
E11 counting resorptions number and on E18 by evaluating
the number of atrophic fetuses in the uterine horns of each
mother.
2.4. Immunostaining of Brain Samples from E18. At embry-
onic day 18 fetuses were decapitated, and the brain was
dissected out. Six fetuses per group randomly selected from
all the obtained fetuses, were used. After PFA 4% fixation of
cerebral tissue, it was maintained in a 30% glucose solution
during 24 hours to cryoprotect the tissue prior to freezing.
Serial coronal slices of tissue were obtained every 20–25
micrometers.
An immunohistochemistry analysis was then performed
to detect cleaved caspase-3 activity and tubuline beta-III in
fetal brains.
Sections were incubated for 45 minutes with blocking
solution containing 5% normal goat serum (NGS, Sigma
St. Louis, MO, USA) and 5% non-fat dry milk, then were
incubated overnight at 4◦C with anticaspase-3-activated
antibody (1 : 200, cell signalling technology).
An antirabbit biotinylated secondary antibody (1 : 400)
was used. Afterwards the Vectastain Elite ABC kit the samples
were used and after further washes in PBS, cleaved caspase-3
labelled cells were visualized using diaminobenzidine (DAB)
plus nickel sulphate solution (Vectastain, Vector laborato-
ries) yielding a black reaction product. After visualization
of Caspase-3 immunoreactivity, sections were rinsed in
PBS and incubated with one drop of Avidin-D blocking
solution for 15 minutes (Avidin-Biotin blocking solution kit,
Vector Laboratories) and rinsed with PBS. Then sections
were incubated overnight at 4◦ with primary antibody anti-
tubulin-beta-III (1 : 250).
Following washes with PBS, sections were blocked with
3% milk in the wash buﬀer and incubated 1 hour with
a secondary antimice antibody (1 : 250). After wards ABC
system was, used and tubuline-beta-III labelled cells were
visualized using DAB solution.
Sections were dehydrated and mounted.
Quantitative analysis of apoptotic positive cells was
done on a Leica microscope equipped with a video camera
(Leica DMR 6000, Leica Microsystems CMS GMBH, Wetzlar,
Germany). Inside positive areas, microphotographs at 20x
were analysed in order to count and compare apoptotic
patterns.
The areas of the CNS that were analysed were: subventric-
ular zone (B11-B12), pallidum zone (B1-B2), preoptic area-
anterior hypothalamus (H24-H25), hypothalamic neuroep-
ithelium (H1), amygdala (A7-A8-A9-A10), and striatum
(B3–B13-B14–B23). Cell counting was performed using the
Image J, an image analyzer software. For each animal, 4
images by area were analyzed to determine the number of
apoptotic cell in these zones.
2.5. Data Analysis. The results are shown as the mean ±
standard error of the mean (SEM). Comparisons between
multiple groups were performed using ANOVA and a
Newman-Keuls post hoc test. An unpaired t-test was done
to make comparisons between the two groups. Significant
diﬀerences were considered to be P < .05. The GraphPad
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Figure 1: Systolic blood pressure evolution in pregnant rat. Control
group shows levels that remain constant along pregnancy except
day 10, when SBP falls, like in human pregnancies. L-NAME
group showed an increase in SBP values in pregnancy, which was
significant from day 6. (E6 P < .05; E10 P < .0001; E18 P < .05).
Prism 4.0. (GraphPad Software INC. La Jolla, CA, USA) and
the SPSS 17.0 (SPSS Inc. Chicago, IL, USA) softwares were
used.
3. Results
SBP showed a significant increase in the L-NAME group in
all the evaluated moments throughout the pregnancy when
compared with the control group, as shown in Figure 1, and
this significance was clear since day 6 of pregnancy (E6 P <
.05, E11 P < .0001 and E18 P < .05) Also, it showed the
presence of proteinuria.
When we analyzed weight gain and biometrical measure-
ments we found a decrease in fetal weight in L-NAME group
on E6 (0,084 ± 0,003 g versus 0,066 ± 0,003 g), E11 (0,313 ±
0,015 g versus 0,204± 0,008 g), and E18 (2,67± 0,11 g versus
1,87 ± 0,04 g) (P < .0001, Figure 2). Also, a placental weight
decrease over a 20% compared to control was observed (0,67
± 0,03 g in control and 0,54 ± 0,02 g in L-NAME group,
P < .001). Macroscopic analysis of fetal organs found that,
like the placenta, there was a decrease in fetal liver in L-
NAME group (P < .05).
There was no significant diﬀerence in CRL and OSL
between groups. However, when we calculated the OSL/CRL
index, there was a statistically significant increase in the L-
NAME group, which represents smaller heads in this group
(OSL/CRL was 0,318 ± 0,009 and 0,476 ± 0,040 in control
and L-NAME group, resp., P < .001) (Figure 3(a)).
Regarding the measurements, there was a significant
diﬀerence in brain weight between control and L-NAME
treated fetuses (0,454 ± 0,008 g and 0,393 ± 0,009, resp.,
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Figure 2: Fetal weight throughout pregnancy. L-NAME group
shows a decrease in all evaluated moments. E8, E11, and E18 P <
.0001.
P < .0001; Figure 3(b)), the brain/fetal weight showed no
significant diﬀerences, althought there was a trend to an
increase index in the L-NAME group. Finally, in L-NAME
group there was a 7-fold higher intrauterine mortality than
in control group. (Figure 4, P < .0001).
3.1. Analysis of Apoptosis in Fetal Brain. L-NAME group
showed an increased pattern of apoptotic activity of the
fetal brain versus the control group (P < .05, Figure 5).
When we analysed specific cerebral areas, we found that in
the pallidum zone of the fetal brain there was a significant
increase in the apoptotic activity detected as compared
to the control group (P = .0028) (Figure 6(a)). In the
subventricular zone there was also a significant increase in
the apoptotic activity (P = .0024) (Figure 6(b)).
However, in the striatum area and in the amygdala 7
there was a decrease in the number of apoptotic cells, being
significant only in the striatum area (P = .036, Figure 6(c)).
Finally, there was a nonsignificant decrease in the apoptotic
activity in the preoptic area, which corresponds to the
anterior hypothalamus.
4. Discussion
The present study has examined how chronic hypoxia model
since the beginning of the pregnancy via NOS inhibition
may produce growth restriction in fetuses, with an increased
mortality, and it also produces apoptotic damage in some
cerebral areas analysed in the third trimester of pregnancy.
The major aim of our study was to determine the presence
of apoptotic damage in fetal brain specimens. Even though
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Figure 3: A- OSL/CRL index, a significant increase was observed in L-NAME group (P < .001). B- Fetal Brain weight in E18, a decrease was
detected in L-NAME group (P < .0001).
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Figure 4: Comparison of intrauterine mortality present in the
groups of study. A clear increase was observed in L-NAME group
(P < .0001).
this prenatal insult may represent some clinical features in
the newborn or adult, we concentrated our eﬀorts in the
histopathological analysis of the damage.
In this model, we observed an increase in SBP plus
the presence of proteinuria in addition to the diﬀerence
in biometrical measurements. These results are consis-
tent with previous reports that demonstrated that NOS
inhibition results in a PE-like syndrome and a decrease
for gestational age fetuses in rats [16], probably due to
blood flow reduction through both uterine arteries during
pregnancy [21]. However, the mechanisms by which chronic
hypoxia acts to reduce this blood flow remain unknown
[22].
It is interesting that fetal weight is reduced, while
fetal length is not aﬀected. In this sense, there also been
studies that human fetuses under chronic hypoxia conditions
suﬀer from asymmetrical growth restriction, especially in
the abdominal circumference (AC) measurements when
compared with the rest of biometrical parameters [23].
Also, AC measurements measured midgestation are the
best predictors for birth weight [24]. A small placenta and
increased mortality, as seen in our model, are also common
findings in this kind of fetuses. As described above, it
could be a good model to determine certain aspects of the
developing fetus under similar conditions than pregnancies
complicated with preeclampsia.
Our main objective was to analyse the possibility of
intrauterine fetal brain damage under conditions described
above independently of labour injury.
A significant brain damage after exposure to chronic
hypoxia was found. Immature brain exposure to chronic
NOS inhibition should be carefully considered, as L-NAME
is not a selective NOS endothelial inhibitor. However, it has
been seen that the NO is harmful for the developing brain,
and we must assume that the total amount of this substance
is decreased in our model.
We have localized significant damage in the SVZ and in
the pallidum zone (PZ). We evaluated the loss of neuronal
cells via apoptosis, as in recent years an increasing body of
evidence has showed that after cerebral hypoxia-ischemia
neuronal cell damage occurs not only via necrosis, but also
through apoptotic processes [25]. The main mechanism of
damage is still unknown. In this sense, there seems to be a
special vulnerability of a specific subpopulation of cells, the
oligodendrocytes, that have been located in the SVZ after
acute perinatal brain injury [12]. It has been also recently
described that the brain damage caused by chronic hypoxia
does not depend directly on oxygen deprivation, but that it
is also an adaptative response via a cytokine function that
becomes maladaptive. However, in our study we did not
analyse the presence of cytokines in fetal brains, as it was not
our major aim [26].
Regarding the PZ, this area is the precursor of planning
and inhibition of voluntary movements, and it has not been
related with perinatal hypoxic damage. Rees et al. [27] found
cortical disturbances in a sheep model of chronic hypoxia
since midgestation. These disturbances were found in a
more developed brain. We studied immature brains under
a nonphisyological hypoxic mechanism that must develop
Journal of Pregnancy 5
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Figure 5: (I) E18 rat brain coronal scheme, black box indicates an increase in apoptotic activity, and black circle shows a decrease (P < .05)
in L-NAME compared to control group. (II) A-B, Overview at lower magnification of E18 CNS in control (A) and L-NAME group (B)
×5. Panels C-D shown at high magnification: positive cleaved caspase 3 immunostained (black arrows) in neuroepithelial cells of anterior
hypothalamus in PE group (D) ×20.
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Figure 6: Analysis of apoptotic activity in fetal brain. A-pallidum zone (P = .0028). B-subventricular zone (P = .0024). C-striatum (P =
.03).
postnatally, and this should be taken in account in further
studies.
5. Conclusions
In summary, our study shows that chronic hypoxia during
pregnancy produces an apoptotic damage in the cerebral
tissues. These results have showed us that the most sensitive
areas to chronic hypoxia prior to birth were SVZ and PZ
when compared to the control group. The consequences of
this damage and the postnatal expression of this damaged
areas need further specific studies.
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